Cytarabine Accord Healthcare 100 mg/ml sol. inj./perf. i.v./s.c. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cytarabine accord healthcare 100 mg/ml sol. inj./perf. i.v./s.c. flac.

accord healthcare b.v. - cytarabine 100 mg/ml - solution injectable/pour perfusion - 100 mg/ml - cytarabine 100 mg/ml - cytarabine

Cytarabine Hikma Onco-Tain 100 mg/ml sol. inj. i.v./s.c./i.m./i.théc. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cytarabine hikma onco-tain 100 mg/ml sol. inj. i.v./s.c./i.m./i.théc. flac.

hikma farmacêutica s.a. - cytarabine 1 g/10 ml - solution injectable - 100 mg/ml - cytarabine 1000 mg - cytarabine

Cytarabine Hikma Onco-Tain 100 mg/ml sol. inj. i.v./s.c./i.m./i.théc. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cytarabine hikma onco-tain 100 mg/ml sol. inj. i.v./s.c./i.m./i.théc. flac.

hikma farmacêutica s.a. - cytarabine 1 g/10 ml - solution injectable - 100 mg/ml - cytarabine 2000 mg - cytarabine

CYTARABINE injection, solution USA - engelsk - NLM (National Library of Medicine)

cytarabine injection, solution

hospira, inc. - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

CYTARABINE injection USA - engelsk - NLM (National Library of Medicine)

cytarabine injection

mylan institutional llc - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

CYTARABINE injection USA - engelsk - NLM (National Library of Medicine)

cytarabine injection

mylan institutional llc - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

CYTARABINE injection, solution USA - engelsk - NLM (National Library of Medicine)

cytarabine injection, solution

hospira, inc. - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and children. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative-free only) is indicated for the prophylaxis and treatment of meningeal leukemia. cytarabine is contraindicated in those patients who are hypersensitive to the drug.

CYTARABINE injection, solution USA - engelsk - NLM (National Library of Medicine)

cytarabine injection, solution

sagent pharmaceuticals - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

CYTARABINE injection, solution USA - engelsk - NLM (National Library of Medicine)

cytarabine injection, solution

sagent pharmaceuticals - cytarabine (unii: 04079a1rdz) (cytarabine - unii:04079a1rdz) - cytarabine injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. intrathecal administration of cytarabine injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia. cytarabine injection is contraindicated in those patients who are hypersensitive to the drug.

PMS-CYTARABINE SOLUTION Canada - engelsk - Health Canada

pms-cytarabine solution

pharmascience inc - cytarabine - solution - 20mg - cytarabine 20mg - antineoplastic agents